but wait, there's much more ....

Still to come:

- Tga, fda and ce approvals - management very confident given they already have them for first gen device

- commercial tie up with major us chemist chains and health insurance providers

- carpet bombing airwaves with advertising of airsonea

- asthma week marketing

- medical endorsements

- ethical funds buy in bulk

- leveraging patents to offer home smartphone monitoring of other lung diseases, snoring, sleep

- new sub shareholder/ takeover talk?

- $1